Simultaneous Spectrophotometric Determination of Benzyl Alcohol and Diclofenac in Pharmaceutical Formulations by Chemometrics Method

Diclofenac sodium (DS) is a drug with analgesic, antipyretic, and anti‐inflammatory properties. It is present in numerous pharmaceutical preparations. In injectable forms, it is usually accompanied by benzyl alcohol (BA) as an excipient, which is used as a blocking anesthetic (4%) and an antiseptic (4–10%). In this work a spectrophotometric methodology was applied in order to determine benzyl alcohol and diclofenac in injectable formulations by applying a multivariate calibration method. By a multivariate calibration method such as partial least squares (PLS), it is possible to obtain a model adjusted to the concentration values of the mixtures used in the calibration range. In this study, the concentration model is based on absorption spectra in the 230–320 nm range for 25 different mixtures of benzyl alcohol and diclofenac. Calibration matrix contains 10–95 and 1–50 μg mL^?1 for benzyl alcohol and diclofenac, respectively. The root mean square errors of prediction (RMSEP) for benzyl alcohol and diclofenac were 3.0776 and 1.7557, respectively. The proposed method was validated by using a set of synthetic sample mixtures and subsequently applied to simultaneous determination of benzyl alcohol and diclofenac in two different pharmaceutical formulations.     

Fourth Order Derivative Spectrophotometric Determination of Benzyl Alcohol in Piroxicam Injections

Piroxicam is a drug with analgesic and anti‐inflammatory properties. It is present in numerous pharmaceutical preparations. Injectable forms usually contain benzyl alcohol as an excipient, which is used as a blocking anesthetic (4%) and an antiseptic (4–10%). In this work, spectrophotometric methodology was used in order to determine benzyl alcohol in piroxicam injectable formulations by applying the fourth derivative method adopting the zero‐crossing technique. The results obtained show that the method has significant advantages over other reported methods and is appropriate for routine pharmaceutical analysis. The method showed excellent linearity in the range of 2–100 μg mL^?1 with limit of detection (S/N = 3) 0.07 μg mL^?1 (6.47 × 10^?7 M). The proposed method could be applied successfully for the determination of benzyl alcohol in injectable formulations with average % recovery of 100 ± 0.61.     

Thin Layer Chromatographic Method for Rapid Identification and Quantification of Corticosteroid Sodium Phosphates in Pharmaceutical Preparations

Abstract

A rapid and inexpensive thin layer chromatography (TLC) procedure for the assay of dexamethasone sodium phosphate (DSP) and betamethasone sodium phosphate (BSP) persent in pharmaceutical preparations is described. Free steroids liberated after alkaline phosphatase reaction is isolated by TLC on silica gel layer and estimated after elution with ethanol. Assay of unesterified steroids and identification of the preservatives like methyl or propyl parabenzoates, phenol, benzyl alcohol etc. may also be carried out by this method without any additional cost. Possibility of using this method for other corticosteroid sodium phosphates (CSP) are discussed.     

Degradation products generated by sonication of benzyl alcohol, a sample preparation solvent for the determination of residual solvents in pharmaceutical bulks, on capillary gas chromatography

Benzyl alcohol used as the sample preparation solvent in the determination of residual solvents in pharmaceutical bulks yielded benzene, toluene, and benzaldehyde on capillary gas chromatography (GC) by sonication. The factors responsible for compounds generated are discussed. The quality of benzyl alcohol and the type of sonicator were not involved in the generation of benzene, toluene, and benzaldehyde, whereas matrix contributions were observed. The degradation profiles of benzyl alcohol and its analogous compounds obtained by pyrolysis-GC/mass spectrometric analysis were similar to those obtained by sonication, suggesting that benzyl alcohol is degraded by the high local heat generated by sonication. Consequently, no matter how long it may take to dissolve bulk substances in benzyl alcohol completely, we do not recommend the use of a sonicator in sample preparation for the determination of residual solvents in pharmaceutical bulks.     

Simultaneous Determination of Bifonazole and Benzyl Alcohol in Pharmaceutical Formulations by Reverse-Phase HPLC

A simple, precise and sensitive reverse-phase high performance liquid chromatographic (RP-HPLC) method has been developed for the quantitation of bifonazole, an imidazole antifungal, simultaneously with benzyl alcohol, used as preservative, in pharmaceutical formulations. Method employed Zorbax Eclipse XDB-C18 (250×4.6 mm i.d., 5 m) column, methanol - ammonium acetate (pH 2; 65 mM) (65:35, v/v, pH^* 3.6) as mobile phase with flow rate of 1 mL min^–1 and variable UV detection at 220 and 252 nm. The proposed method was validated by testing its linearity, selectivity, recovery, repeatability, LOD/LOQ values and it was successfully employed for the determination of bifonazole and benzyl alcohol in pharmaceutical cream-based formulations.     

Toward the Rationalization of Facilitated Hydrotropy: Investigation with the Ternary Dimethyl Isosorbide / Benzyl Alcohol / Water System

Solubility enhancement has been achieved by facilitated hydrotropy for the dimethyl isosorbide (DMI) / benzyl alcohol / water system. Facilitated hydrotropy has been studied via three different approaches: the solubilization in water of a hydrophobic dye, the evolution of the surface tension and dynamic light scattering, all as a function of the benzyl alcohol concentration. The facilitated hydrotropy has been rationalized from the solubilization properties of the system according to the ratio between the insoluble hydrotrope (here benzyl alcohol, a preservative used in parenteral injections) and the bio-sourced co-solvant (here the dimethyl isosorbide ether, DMI, a solvent used in pharmaceutical formulation). The presence of self-associated nanostructures has been detected by dynamic light scattering (DLS). It appears that the cosolvent, DMI, has an antagonistic action: DMI increases the facilitated hydrotrope (benzyl alcohol) solubility in the aqueous solution (favoring solute solubilization) but simultaneously decreases the hydrotropic efficiency of benzyl alcohol.     

A novel efficient deoxygenation process for N-heteroarene N-oxides

A novel deoxygenation process for N-heteroarene N-oxides is described. The deoxygenation process has been carried out by utilizing some short C-chain alcohols, benzyl alcohol, or 1-phenylethanol as the solvent in the presence of a base, such as sodium alkoxide or sodium hydroxide. A series of N-heteroarene N-oxides was submitted to the developed conditions to provide the corresponding N-heteroarenes with high yield and excellent selectivity. When the deoxygenation is carried out with benzyl alcohol or 1-phenylethanol as the reaction medium, the process can be performed under very mild conditions, at only 30 degrees C. The deoxygenation process is in contrast to several other methods performed without the presence of any transition metal as a catalyst or stoichiometric reagent. DFT calculations suggest that the alkoxide performs a nucleophilic attack on the N-heteroarene in the ortho or para position. This bond is cleaved homolytically with the overall result being that a single electron-transfer step has occurred. The products of this process are an N-heteroarene N-oxide radical anion and an alkoxyl or benzyloxy radical, depending on the solvent that has been used. Successive steps of the mechanism result in an oxygen transfer from the N-oxide to give the deoxygenated N-heteroarene and 1 equiv of the aldehyde, which is the oxidation product of the solvent alcohol.     

硫酸氢钠催化合成羧酸苄酯

讨论了一水硫酸氢钠催化合成乙酸苄酯的条件。羧酸、苄醇和硫酸氢钠的质量比为 3∶2∶0 .1 45 ,以环己烷为溶剂 ,进行回流分水 ,合成了甲酸苄酯、乙酸苄酯、丙酸苄酯和丁酸苄酯 ,其收率为 68.5 %～ 84.1 %     

胶束溶液增溶过程的高分辩NMR研究

本文用高分辨~1H-NMR谱, 研究了十二烷基硫酸钠(SDS)胶束水溶液对m-二甲苯和苯甲醇的增溶作用。结果表明, 增溶物浓度很低时, m-二甲苯和苯甲醇均吸附在胶束-水“界面”。随着浓度增加m-二甲苯增溶在胶束的“栅栏”层和内核中, 并沿SDS的烃链均匀分布。当浓度约为0.34摩尔分数时, 它沿烃链的增溶达到“饱和”, 开始进入胶束内核中心。苯甲醇主要增溶在“栅栏”层中, 其羟基靠近胶束-水“界面”, 苯基深入到与α-CH_2基相邻的五个亚甲基的位置。     

Solid Phase Catalytic Oxidation of Alcohols by Polymer Supported Rare Earth Catalysts

Oxidation of alcohols to the corresponding aldehydes or ketones is one of the most fundamental reactions in organic chemistry [1,2]. Some of the products of the oxidation exhibit an important role in the organic synthesis as well as pharmaceutical synthesis. In most reactions, the lanthanide complexes show satisfied catalytic activities for some compounds. Furthermore, there has been increasing interest in the lanthanide complexes and several reports have appeared in the literature [3, 4]. But the exploitation of these complexes for the oxidation of some organic substrates has been limited. Here we reported a method for the preparation and the catalytic properties as well as the recycling of lanthanide complexes in oxidation of alcohols.The synthetic procedure for the polymer supported lanthanide complexes is shown as following(scheme 1):●-NH2+CICH2COOH(C2Hs)3N→●-NHCH2COOHM=Ce(Ⅲ), Tb(Ⅲ), Sm(Ⅲ)scheme 1The oxidation of benzyl alcohol was carried out in the presence of iodosylbenzene by the polymer supported Ce(Ⅲ), Tb(Ⅲ) and Sm(Ⅲ) catalysts at 80℃ for 4.0h, the yields of benz-aldehyde are as following (table 1):Table 1 Oxidation of benzyl alcohol with the supported catalysts**Reaction condition: benzyl alcohol 0.1 mmol, iodosylbenzene 0.15mmol,catalyst 0.2mg, 80℃ for 4.0h in 1,2-dichloroethane.It can be seen from the table that the Tb(Ⅲ) complex shows higher catalytic activity for the oxidation of benzyl alcohol. Further investigation is now being carded on to optimize the results.     

钠对苯甲醛加氢合成苯甲醇催化剂Cu/SiO2的修饰作用影响活性

采用浸渍法引入不同含量的钠元素对Cu/SiO₂催化剂进行了改性, 并对苯甲醛加氢合成无氯苯甲醇反应进行了研究. XRD, H₂-TPR, BET, IR等表征分析结果表明: 经钠元素修饰后的催化剂并没有改变CuO的晶相结构, 但增强了活性组分和载体间的相互作用, 使CuO的还原温度得到提高; 催化剂表面的酸量和酸强度随钠元素修饰量的增加而显著降低; 钠的最佳负载量为1.0% (w), Na-Cu/SiO₂催化剂能够有效抑制副产物甲苯的生成, 显著地提高产物苯甲醇的高温选择性.     

Quantification of lysine clonixinate in intravenous injections by NIR spectroscopy

Migraine is a very painful and somewhat unpredictable ache that affects millions of people worldwide and for which no definite medicine exists, yet. New drugs and/or pharmaceutical forms are being developed, for which new quantitation methods are required. Lysine clonixinate (LC) has proved very advantageous to alleviate migraine episodes although, so far, no analytical procedures have been reported to quantify it in pharmaceutical dosage forms usually employed by physicians, i.e., injectable solutions. In this paper a NIR spectral method was developed and validated against international pharmaceutical standard guidelines and a new UV-based method to quantify LC in intravenous injection solutions. Both methods are almost inexpensive, fast, simple and suitable for LC routine determination. In addition, they provide analytical protocols less time-consuming than other reported HPLC methods (developed for other matrices), proved to be specific, accurate, precise and linear within the typical working range, according to the Harmonized Tripartite Guideline of Validation of Analytical Procedures from the International Conference on Harmonization. Both methods yield equivalent results and they are useful to monitor the concentration of LC in injectable solutions in routine analysis.     

Quantification of lysine clonixinate in intravenous injections by NIR spectroscopy

Migraine is a very painful and somewhat unpredictable ache that affects millions of people worldwide and for which no definite medicine exists, yet. New drugs and/or pharmaceutical forms are being developed, for which new quantitation methods are required. Lysine clonixinate (LC) has proved very advantageous to alleviate migraine episodes although, so far, no analytical procedures have been reported to quantify it in pharmaceutical dosage forms usually employed by physicians, i.e., injectable solutions. In this paper a NIR spectral method was developed and validated against international pharmaceutical standard guidelines and a new UV-based method to quantify LC in intravenous injection solutions. Both methods are almost inexpensive, fast, simple and suitable for LC routine determination. In addition, they provide analytical protocols less time-consuming than other reported HPLC methods (developed for other matrices), proved to be specific, accurate, precise and linear within the typical working range, according to the Harmonized Tripartite Guideline of Validation of Analytical Procedures from the International Conference on Harmonization. Both methods yield equivalent results and they are useful to monitor the concentration of LC in injectable solutions in routine analysis.     

Selectivity modulation in the consecutive hydrogenation of benzaldehyde via functionalization of carbon nanotubes

Hydrogenation of benzaldehyde is a typical consecutive reaction,since the intermediate benzyl alcohol is apt to be further hydrogenated.Here we demonstrate that the selectivity of benzyl alcohol can be tuned via functionalization of carbon nanotubes(CNTs),which are used as the support of Pd.With the original CNTs,the selectivity of benzyl alcohol is 88% at a 100% conversion of benzaldehyde.With introduction of oxygen-containing groups onto CNTs,it drops to 27%.In contrast,doping CNTs with N atoms,the selectivity reaches 96% under the same reaction conditions.The kinetic study shows that hydrogenation of benzyl alcohol is significantly suppressed,which can be attributed to weakened adsorption of benzyl alcohol.This is most likely related to the modified electronic structure of Pd species via interaction with functionalized CNTs,as shown by XPS characterization.     

Real‐Time Detection of Traces of Benzaldehyde in Benzyl Alcohol as a Solvent by a Flexible Lanthanide Microporous Metal–Organic Framework

Luminescent 3D lanthanide metal–organic framework (Ln‐MOF) {[Tb₂(TATAB)₂] ? 4 H₂O ? 6 DMF}_n ( 1 ) was synthesized under solvothermal conditions by using flexible ligand 4,4′,4′′‐s‐triazine‐1,3,5‐triyltri‐p‐aminobenzoate (TATAB). A phase transition was observed between low temperature and room temperature. The luminescence of 1 could be enhanced by formaldehyde and quenched efficiently by trace amounts of benzaldehyde in solvents such as benzyl alcohol (0.01–2.0 vol %) and ethanol (0.01–2.5 vol %). This is the first use of a Ln‐MOF as chemical sensor for both formaldehyde and benzaldehyde. The high sensitivity and selectivity of the luminescence response of 1 to benzaldehyde allows it to be used as an excellent sensor for identifying benzaldehyde and provides a simple and convenient method for detecting traces of benzaldehyde in benzyl alcohol based injections. This work establishes a new strategy for detection of benzaldehyde in benzyl alcohol by luminescent MOFs.     

Determination of benzyl alcohol and its metabolite in plasma by reversed-phase high-performance liquid chromatography.

A study undertaken following recent reports of deaths in neonatal children associated with the use of benzyl alcohol resulted in the development of a stability-indicating high-performance liquid chromatographic assay of benzyl alcohol in plasma using benzocaine as internal standard. Thawed plasma samples were diluted and subjected to solid-phase extraction using Extrelut and eluted with ethyl acetate. The evaporated eluate was reconstituted with mobile phase and chromatographed on a C18 column with water-acetonitrile-glacial acetic acid as mobile phase and detection at 254 nm. Baseline separation was achieved within 12 min for benzyl alcohol, benzaldehyde, benzoic acid, hippuric acid and benzocaine. Peak-height ratios were linear over 80-640 ng of benzyl alcohol injected (r = 0.998) and over 10-80 ng of benzoic acid injected (r = 0.999). Benzaldehyde and hippuric acid were not quantitated because these compounds were not detectable in actual dog plasma. Validation studies by spiking dog plasma with benzyl alcohol and benzoic acid gave overall percent recoveries (+/- relative standard deviation, n = 4) of 98.3 +/- 3.0 and 101.4 +/- 7.6%, respectively. The method was applied to the assay of actual plasma samples. Since benzyl alcohol is very susceptible to oxidation to benzaldehyde and benzoic acid, its purity in bulk liquid samples can be determined by this method.     

K-MnO／y-A1203和Cu／SiO2催化剂应用于苯甲酸甲酯连续加氢合成无氯苯甲醇

以K—MnO／F—Al2O3和Cu／SiO2为催化剂，利用固定床串联反应器实现了苯甲酸甲酯连续加氢合成无氯苯甲醇反应过程．K-MnO/y-Al2O3和Cu／SiO2催化剂对于苯甲酸甲酯连续加氢合成苯甲醇具有良好的加氢活性，反应转化率可达89．2％，苯甲醇的选择性为84．1％．在苯甲酸甲酯加氢连续步骤中的氢醛比得到提高，有效地抑制了副产物甲苯的生成．XRD，SEM和TPR表征结果表明：采用吸附沉淀法制备的Cu／SiO2-C15．2催化剂，氧化铜在载体上具有良好的分散性能，并且易于还原，表现出最佳的苯甲醛加氢活性．     

酸性功能化离子液体催化合成叶青素

以含磺酸基离子液体1-(4-磺酸基)丁基-3-甲基咪唑四氟硼酸盐([4-sulfbmim][BF₄])为酸性催化剂,由乙缩醛和苯甲醇合成了叶青素。 采用正交实验方法考察了合成条件的影响,固定反应温度为20 ℃条件下,确定优化合成条件为：n(苯甲醇)∶n(乙缩醛)=1∶8,反应时间60 min,催化剂用量为每摩尔苯甲醇4 g,产率为92.2%。 与H₂SO₄催化剂相比[4-sulfbmim][BF₄]的催化活性相对较弱,但综合效果优于H₂SO₄。 [4-sulfbmim][BF₄]循环使用6次,催化活性基本不变。     

Gas-chromatographic determination of formic acid in the oxidation products of organic substances

Procedures for the gas-chromatographic determination of formic acid in oxidation produts of organic substances after its conversion to benzyl formate were developed. In determining formic acid in an organic phase, free formic acid was esterified with benzyl alcohol in a pyridine solution while adding acetic anhydride under mild conditions. The conversion of formic acid was complete even in the presence of other mono-and dicarboxylic acids in considerable amounts. It was found that the formation of benzyl formate occurred via a mixed aldehyde formed in situ from formic acid and acetic anhydride. The determination of formic acid in aqueous solutions involves the synthesis of its sodium or potassium salt and the successive treatment of this salt with acetyl chloride and benzyl alcohol in a pyridine solution.     

钨过氧酸盐离子液体催化过氧化氢氧化苯甲醇制苯甲酸

用甲基三辛基氯化铵和钨酸钠一步法合成甲基三辛基季铵钨酸盐离子液体[(CH3)N(n-C8H17)3]2W2O11,以该离子液体为催化剂,在无反应溶剂条件下催化过氧化氢氧化苯甲醇生成苯甲酸。 考察了反应温度、催化剂用量以及氧化剂过氧化氢用量对苯甲酸产率的影响。 确定优化条件：反应温度70 ℃,苯甲醇用量5 mmol,催化剂用量是底物的0.4%(摩尔分数),30%过氧化氢用量2 mL,苯甲醇的转化率可达99%,苯甲酸选择性为98%。 该方法具有反应条件温和、产率高和选择性好的优点。